![Sam Bakri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Sam Bakri
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Solascure Ltd.
![]() Solascure Ltd. Medical SpecialtiesHealth Technology Solascure Ltd. operates as a biotech company that develops wound care products. The company was founded by Benjamin Newmark and Sam Bakri in 2017 and is headquartered in Cardiff, the United Kingdom. | Vorsitzender | 01.01.2017 | - |
Gründer | 01.01.2017 | - | |
Gelmetix Ltd.
![]() Gelmetix Ltd. Miscellaneous Commercial ServicesCommercial Services Gelmetix Ltd. offers a non-surgical procedure for the treatment of chronic lower back pain caused by degenerative disc disease. The firm develops a hydrogel to relieve back pain by enabling cells in the spinal disc to get back to normal functioning, which can be injected into the disc by a healthcare professional and replaces the need for invasive back surgery. The company was founded by Tony Freemont and Brian Saunders in 2012 and is headquartered in Cheshire, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Sam Bakri
Statistik
International
Vereinigtes Königreich | 3 |
Operativ
Chairman | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Solascure Ltd.
![]() Solascure Ltd. Medical SpecialtiesHealth Technology Solascure Ltd. operates as a biotech company that develops wound care products. The company was founded by Benjamin Newmark and Sam Bakri in 2017 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Gelmetix Ltd.
![]() Gelmetix Ltd. Miscellaneous Commercial ServicesCommercial Services Gelmetix Ltd. offers a non-surgical procedure for the treatment of chronic lower back pain caused by degenerative disc disease. The firm develops a hydrogel to relieve back pain by enabling cells in the spinal disc to get back to normal functioning, which can be injected into the disc by a healthcare professional and replaces the need for invasive back surgery. The company was founded by Tony Freemont and Brian Saunders in 2012 and is headquartered in Cheshire, the United Kingdom. | Commercial Services |